Latest filings (excl ownership)
8-K
W. Austin Lewis IV, Chairman of the Board
6 May 19
8-K
Other Events
23 Apr 19
15-12G/A
Securities registration termination (amended)
2 Apr 19
NT 10-K
Notice of late annual filing
1 Apr 19
15-12G
Securities registration termination
22 Mar 19
8-K
Departure of Directors or Certain Officers
18 Mar 19
PRE 14C
Preliminary information
28 Feb 19
8-K
Bankruptcy or Receivership
3 Jan 19
8-K
Entry into a Material Definitive Agreement
6 Dec 18
10-Q
2018 Q3
Quarterly report
14 Nov 18
8-K/A
Departure of Directors or Certain Officers
7 Nov 18
8-K
Departure of Directors or Certain Officers
31 Oct 18
D
$1M in equity / debt / options / securities to be acquired, sold $870K, 3 investors
26 Oct 18
8-K
Entry into a Material Definitive Agreement
16 Oct 18
8-K
Entry into a Material Definitive Agreement
1 Oct 18
DEF 14C
Information statement
6 Sep 18
PRE 14C
Preliminary information
27 Aug 18
10-Q
2018 Q2
Quarterly report
10 Aug 18
8-K
Entry into a Material Definitive Agreement
30 Jul 18
8-K
Entry into a Material Definitive Agreement
18 Jul 18
8-K
Entry into a Material Definitive Agreement
13 Jul 18
D
$1M in equity / debt / options, sold $850K, 2 investors
12 Jul 18
10-Q
2018 Q1
Quarterly report
22 Jun 18
10-K
2017 FY
Annual report
17 May 18
NT 10-Q
Notice of late quarterly filing
14 May 18
8-K
Entry into a Material Definitive Agreement
1 May 18
NT 10-K
Notice of late annual filing
29 Mar 18
8-K
Entry into a Material Definitive Agreement
5 Mar 18
8-K
Entry into a Material Definitive Agreement
26 Feb 18
D
$1.5M in equity / debt / options / securities to be acquired, sold $1.19M, 5 investors
22 Feb 18
8-K
Entry into a Material Definitive Agreement
20 Feb 18
8-K
Entry into a Material Definitive Agreement
12 Feb 18
8-K
Entry into a Material Definitive Agreement
9 Feb 18
8-K
Departure of Directors or Certain Officers
30 Jan 18
8-K
Departure of Directors or Certain Officers
17 Jan 18
8-K
Departure of Directors or Certain Officers
5 Jan 18
10-Q
2017 Q3
Quarterly report
14 Nov 17
8-K
MEDITE Cancer Diagnostics Reports Appointments of New Chairman of the Board and Chief Executive Officer
8 Nov 17
D
$6.86M in equity / debt / options / securities to be acquired, sold $5.93M, 6 investors
16 Oct 17
8-K
Entry into a Material Definitive Agreement
2 Oct 17
Latest ownership filings
SC 13G/A
Medite Cancer Diagnostics, Inc.
2 Nov 18
4
JOHN H ABELES
23 Oct 18
4
William Austin IV Lewis
19 Oct 18
4
William Austin IV Lewis
30 Jul 18
4
Rump Stephen L. Von
30 Jul 18
3
Rump Stephen L. Von
20 Jul 18
4
William Austin IV Lewis
12 Jul 18
4
JOHN H ABELES
10 Jul 18
4
William Austin IV Lewis
5 Jul 18
4
GREGORY FORTUNOFF
8 May 18
3
GREGORY FORTUNOFF
8 May 18
3
JOEL S KANTER
4 May 18
SC 13G
Medite Cancer Diagnostics, Inc.
28 Feb 18
3
William Austin IV Lewis
12 Feb 18
3/A
William Austin IV Lewis
12 Feb 18
4
William Austin IV Lewis
12 Feb 18
3
Susan Weisman
16 Nov 17
4
Susan Weisman
16 Nov 17
3
Eric Michael Goehausen
21 Mar 17
4
Michaela Ott
5 Oct 15
4
Michael Egbert Ott
5 Oct 15
SC 13D
CytoCore Inc
15 Apr 14